ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus Entry

PLoS Pathogens

Volumn 11, Issue 9, 2015, Pages

  Shu, Qian ^a,b   Lennemann, Nicholas J ^b   Sarkar, Saumendra N ^b,c   Sadovsky, Yoel ^d   Coyne, Carolyn B ^b,d  

^a Tsinghua University   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; SMALL INTERFERING RNA; STAT1 PROTEIN; ADAP2 PROTEIN, HUMAN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ADP-RIBOSYLATION FACTOR 6; BETA INTERFERON; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HYBRID PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4-DIPHOSPHATE; POLYPHOSPHOINOSITIDE; STAT1 PROTEIN, HUMAN;

ADAP2 GENE; ANTIBODY RESPONSE; ARTICLE; FLUORESCENCE ANALYSIS; GENE; GENE CONTROL; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; INNATE IMMUNITY; INTERFERON STIMULATED GENE; LIFE CYCLE STAGE; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENESIS; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA VIRUS INFECTION; VESICULAR STOMATITIS; VIRAL GENE DELIVERY SYSTEM; VIRUS ENTRY; VIRUS REPLICATION; AGONISTS; ANIMAL; CELL LINE; CHEMISTRY; CHLOROCEBUS AETHIOPS; DENGUE VIRUS; ENTEROVIRUS B; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MUTATION; PHYSIOLOGY; PINOCYTOSIS; SENDAI VIRUS; VERO CELL LINE; VESICULOVIRUS; VIRION;

ADP-RIBOSYLATION FACTORS; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DENGUE VIRUS; ENTEROVIRUS B, HUMAN; GTPASE-ACTIVATING PROTEINS; HUMANS; INTERFERON-BETA; MUTATION; PHOSPHATIDYLINOSITOL PHOSPHATES; PINOCYTOSIS; RECOMBINANT FUSION PROTEINS; SENDAI VIRUS; STAT1 TRANSCRIPTION FACTOR; VERO CELLS; VESICULOVIRUS; VIRION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84943576591     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005150     Document Type: Article

References (62)

1. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481–5. doi: 10.1038/nature09907 21478870; PubMed Central PMCID: PMC3409588.
2. Perreira JM, Chin CR, Feeley EM, Brass AL, IFITMs restrict the replication of multiple pathogenic viruses. Journal of molecular biology. 2013;425(24):4937–55. doi: 10.1016/j.jmb.2013.09.024 24076421; PubMed Central PMCID: PMC4121887.
3. Diamond MS, Farzan M, The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nature reviews Immunology. 2013;13(1):46–57. doi: 10.1038/nri3344 23237964; PubMed Central PMCID: PMC3773942.
4. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell. 2009;139(7):1243–54. doi: 10.1016/j.cell.2009.12.017 20064371; PubMed Central PMCID: PMC2824905.
5. Lu J, Pan Q, Rong L, He W, Liu SL, Liang C, The IFITM proteins inhibit HIV-1 infection. Journal of virology. 2011;85(5):2126–37. doi: 10.1128/JVI.01531-10 21177806; PubMed Central PMCID: PMC3067758.
6. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS pathogens. 2011;7(1):e1001258. doi: 10.1371/journal.ppat.1001258 21253575; PubMed Central PMCID: PMC3017121.
7. Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, Farzan M, et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell host & microbe. 2013;13(4):452–64. doi: 10.1016/j.chom.2013.03.006 23601107; PubMed Central PMCID: PMC3646482.
8. Desai TM, Marin M, Chin CR, Savidis G, Brass AL, Melikyan GB, IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS pathogens. 2014;10(4):e1004048. doi: 10.1371/journal.ppat.1004048 24699674; PubMed Central PMCID: PMC3974867.
9. Lin TY, Chin CR, Everitt AR, Clare S, Perreira JM, Savidis G, et al. Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell Rep. 2013;5(4):895–908. doi: 10.1016/j.celrep.2013.10.033 24268777; PubMed Central PMCID: PMC3898084.
10. Sun X, Yau VK, Briggs BJ, Whittaker GR, Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology. 2005;338(1):53–60. doi: 10.1016/j.virol.2005.05.006 15936793.
11. Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A, Host cell factors and functions involved in vesicular stomatitis virus entry. Journal of virology. 2009;83(1):440–53. doi: 10.1128/JVI.01864-08 18971266; PubMed Central PMCID: PMC2612308.
12. Coyne CB, Bergelson JM, Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell. 2006;124(1):119–31. doi: 10.1016/j.cell.2005.10.035 16413486.
13. Bozym RA, Patel K, White C, Cheung KH, Bergelson JM, Morosky SA, et al. Calcium signals and calpain-dependent necrosis are essential for release of coxsackievirus B from polarized intestinal epithelial cells. Molecular biology of the cell. 2011;22(17):3010–21. doi: 10.1091/mbc.E11-02-0094 21737691; PubMed Central PMCID: PMC3164450.
14. Patel KP, Coyne CB, Bergelson JM, Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells. Journal of virology. 2009;83(21):11064–77. doi: 10.1128/JVI.01016-09 19710132; PubMed Central PMCID: PMC2772800.
15. Fan DP, Sefton BM, The entry into host cells of Sindbis virus, vesicular stomatitis virus and Sendai virus. Cell. 1978;15(3):985–92. 215317.
16. Acosta EG, Castilla V, Damonte EB, Infectious dengue-1 virus entry into mosquito C6/36 cells. Virus research. 2011;160(1–2):173–9. doi: 10.1016/j.virusres.2011.06.008 21708195.
17. Vancini R, Kramer LD, Ribeiro M, Hernandez R, Brown D, Flavivirus infection from mosquitoes in vitro reveals cell entry at the plasma membrane. Virology. 2013;435(2):406–14. doi: 10.1016/j.virol.2012.10.013 23099205.
18. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, Zhuang X, et al. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS pathogens. 2008;4(12):e1000244. doi: 10.1371/journal.ppat.1000244 19096510; PubMed Central PMCID: PMC2592694.
19. Radhakrishna H, Al-Awar O, Khachikian Z, Donaldson JG, ARF6 requirement for Rac ruffling suggests a role for membrane trafficking in cortical actin rearrangements. Journal of cell science. 1999;112 (Pt 6):855–66. 10036235.
20. Santy LC, Casanova JE, Activation of ARF6 by ARNO stimulates epithelial cell migration through downstream activation of both Rac1 and phospholipase D. The Journal of cell biology. 2001;154(3):599–610. doi: 10.1083/jcb.200104019 11481345; PubMed Central PMCID: PMC2196419.
21. Ge M, Cohen JS, Brown HA, Freed JH, ADP ribosylation factor 6 binding to phosphatidylinositol 4,5-bisphosphate-containing vesicles creates defects in the bilayer structure: an electron spin resonance study. Biophysical journal. 2001;81(2):994–1005. doi: 10.1016/S0006-3495(01)75757-8 11463641; PubMed Central PMCID: PMC1301569.
22. Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H, Watanabe H, et al. Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell. 1999;99(5):521–32. 10589680.
23. Venkateswarlu K, Brandom KG, Yun H, PI-3-kinase-dependent membrane recruitment of centaurin-alpha2 is essential for its effect on ARF6-mediated actin cytoskeleton reorganisation. Journal of cell science. 2007;120(Pt 5):792–801. doi: 10.1242/jcs.03373 17284522.
24. Tanaka K, Imajoh-Ohmi S, Sawada T, Shirai R, Hashimoto Y, Iwasaki S, et al. A target of phosphatidylinositol 3,4,5-trisphosphate with a zinc finger motif similar to that of the ADP-ribosylation-factor GTPase-activating protein and two pleckstrin homology domains. European journal of biochemistry / FEBS. 1997;245(2):512–9. 9151987.
25. Hammonds-Odie LP, Jackson TR, Profit AA, Blader IJ, Turck CW, Prestwich GD, et al. Identification and cloning of centaurin-alpha. A novel phosphatidylinositol 3,4,5-trisphosphate-binding protein from rat brain. The Journal of biological chemistry. 1996;271(31):18859–68. 8702546.
26. Sun P, Yamamoto H, Suetsugu S, Miki H, Takenawa T, Endo T, Small GTPase Rah/Rab34 is associated with membrane ruffles and macropinosomes and promotes macropinosome formation. The Journal of biological chemistry. 2003;278(6):4063–71. doi: 10.1074/jbc.M208699200 12446704.
27. Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. The Journal of cell biology. 2010;188(4):547–63. doi: 10.1083/jcb.200908086 20156964; PubMed Central PMCID: PMC2828922.
28. Hattula K, Furuhjelm J, Tikkanen J, Tanhuanpaa K, Laakkonen P, Peranen J, Characterization of the Rab8-specific membrane traffic route linked to protrusion formation. Journal of cell science. 2006;119(Pt 23):4866–77. doi: 10.1242/jcs.03275 17105768.
29. Linder MD, Uronen RL, Holtta-Vuori M, van der Sluijs P, Peranen J, Ikonen E, Rab8-dependent recycling promotes endosomal cholesterol removal in normal and sphingolipidosis cells. Molecular biology of the cell. 2007;18(1):47–56. doi: 10.1091/mbc.E06-07-0575 17050734; PubMed Central PMCID: PMC1751315.
30. Hewlett LJ, Prescott AR, Watts C, The coated pit and macropinocytic pathways serve distinct endosome populations. The Journal of cell biology. 1994;124(5):689–703. 8120092; PubMed Central PMCID: PMC2119947.
31. Racoosin EL, Swanson JA, Macropinosome maturation and fusion with tubular lysosomes in macrophages. The Journal of cell biology. 1993;121(5):1011–20. 8099075; PubMed Central PMCID: PMC2119679.
32. Mire CE, White JM, Whitt MA, A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating. PLoS pathogens. 2010;6(7):e1000994. doi: 10.1371/journal.ppat.1000994 20657818; PubMed Central PMCID: PMC2904772.
33. Brandenburg B, Lee LY, Lakadamyali M, Rust MJ, Zhuang X, Hogle JM, Imaging poliovirus entry in live cells. PLoS Biol. 2007;5(7):e183. Epub 2007/07/12. doi: 06-PLBI-RA-2449 [pii] doi: 10.1371/journal.pbio.0050183 17622193.
34. Crowther D, Melnick JL, The incorporation of neutral red and acridine orange into developing poliovirus particles making them photosensitive. Virology. 1961;14:11–21. Epub 1961/05/01. 13696675.
35. Wilson JN, Cooper PD, ASPECTS OF THE GROWTH OF POLIOVIRUS AS REVEALED BY THE PHOTODYNAMIC EFFECTS OF NEUTRAL RED AND ACRIDINE ORANGE. Virology. 1963;21:135–45. Epub 1963/10/01. 14070166.
36. Delorme-Axford E, Sadovsky Y, Coyne CB, Lipid raft- and SRC family kinase-dependent entry of coxsackievirus B into human placental trophoblasts. Journal of virology. 2013;87(15):8569–81. Epub 2013/05/31. doi: 10.1128/jvi.00708-13 23720726; PubMed Central PMCID: PMCPmc3719791.
37. Kim C, Bergelson JM, Echovirus 7 entry into polarized caco-2 intestinal epithelial cells involves core components of the autophagy machinery. Journal of virology. 2014;88(1):434–43. doi: 10.1128/JVI.02706-13 24155402; PubMed Central PMCID: PMC3911758.
38. Whitley P, Gibbard AM, Koumanov F, Oldfield S, Kilgour EE, Prestwich GD, et al. Identification of centaurin-alpha2: a phosphatidylinositide-binding protein present in fat, heart and skeletal muscle. European journal of cell biology. 2002;81(4):222–30. 12018390.
39. Hanck T, Stricker R, Sedehizade F, Reiser G, Identification of gene structure and subcellular localization of human centaurin alpha 2, and p42IP4, a family of two highly homologous, Ins 1,3,4,5-P4-/PtdIns 3,4,5-P3-binding, adapter proteins. Journal of neurochemistry. 2004;88(2):326–36. 14690521.
40. Aggensteiner M, Reiser G, Expression of the brain-specific membrane adapter protein p42IP4/centaurin alpha, a Ins(1,3,4,5)P4/PtdIns(3,4,5)P3 binding protein, in developing rat brain. Brain research Developmental brain research. 2003;142(1):77–87. 12694946.
41. Venkateswarlu K, Cullen PJ, Molecular cloning and functional characterization of a human homologue of centaurin-alpha. Biochemical and biophysical research communications. 1999;262(1):237–44. doi: 10.1006/bbrc.1999.1065 10448098.
42. Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, Noureddin M, et al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology. 2012;142(4):978–88. doi: 10.1053/j.gastro.2011.12.055 22248663; PubMed Central PMCID: PMC3435150.
43. Tao Y, Zhang X, Chopra M, Kim MJ, Buch KR, Kong D, et al. The role of endogenous IFN-beta in the regulation of Th17 responses in patients with relapsing-remitting multiple sclerosis. Journal of immunology. 2014;192(12):5610–7. doi: 10.4049/jimmunol.1302580 24850724.
44. Krishnan MN, Sukumaran B, Pal U, Agaisse H, Murray JL, Hodge TW, et al. Rab 5 is required for the cellular entry of dengue and West Nile viruses. Journal of virology. 2007;81(9):4881–5. doi: 10.1128/JVI.02210-06 17301152; PubMed Central PMCID: PMC1900185.
45. Carneiro FA, Ferradosa AS, Da Poian AT, Low pH-induced conformational changes in vesicular stomatitis virus glycoprotein involve dramatic structure reorganization. The Journal of biological chemistry. 2001;276(1):62–7. doi: 10.1074/jbc.M008753200 11024041.
46. White J, Matlin K, Helenius A, Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. The Journal of cell biology. 1981;89(3):674–9. 6265470; PubMed Central PMCID: PMC2111813.
47. Al-Awar O, Radhakrishna H, Powell NN, Donaldson JG, Separation of membrane trafficking and actin remodeling functions of ARF6 with an effector domain mutant. Molecular and cellular biology. 2000;20(16):5998–6007. 10913182; PubMed Central PMCID: PMC86076.
48. Naslavsky N, Weigert R, Donaldson JG, Convergence of non-clathrin- and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides. Molecular biology of the cell. 2003;14(2):417–31. doi: 10.1091/mbc.02-04-0053 12589044; PubMed Central PMCID: PMC149982.
49. Klein S, Franco M, Chardin P, Luton F, Role of the Arf6 GDP/GTP cycle and Arf6 GTPase-activating proteins in actin remodeling and intracellular transport. The Journal of biological chemistry. 2006;281(18):12352–61. doi: 10.1074/jbc.M601021200 16527809.
50. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG, Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. The Journal of cell biology. 2001;154(5):1007–17. doi: 10.1083/jcb.200103107 11535619; PubMed Central PMCID: PMC2196179.
51. Davidson AC, Humphreys D, Brooks AB, Hume PJ, Koronakis V, The Arf GTPase-activating protein family is exploited by Salmonella enterica serovar Typhimurium to invade nonphagocytic host cells. mBio. 2015;6(1). doi: 10.1128/mBio.02253-14 25670778; PubMed Central PMCID: PMC4337568.
52. McKendry R, John J, Flavell D, Muller M, Kerr IM, Stark GR, High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proceedings of the National Academy of Sciences of the United States of America. 1991;88(24):11455–9. 1837150; PubMed Central PMCID: PMC53154.
53. Vasilakis N, Fokam EB, Hanson CT, Weinberg E, Sall AA, Whitehead SS, et al. Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains. Virology. 2008;377(2):296–307. doi: 10.1016/j.virol.2008.04.044 18570968; PubMed Central PMCID: PMC3612928.
54. Shum D, Smith JL, Hirsch AJ, Bhinder B, Radu C, Stein DA, et al. High-content assay to identify inhibitors of dengue virus infection. Assay and drug development technologies. 2010;8(5):553–70. Epub 2010/10/27. doi: 10.1089/adt.2010.0321 20973722; PubMed Central PMCID: PMCPmc2962577.
55. Bozym RA, Delorme-Axford E, Harris K, Morosky S, Ikizler M, Dermody TS, et al. Focal adhesion kinase is a component of antiviral RIG-I-like receptor signaling. Cell host & microbe. 2012;11(2):153–66. doi: 10.1016/j.chom.2012.01.008 22341464.
56. Coyne CB, Shen L, Turner JR, Bergelson JM, Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell host & microbe. 2007;2(3):181–92. Epub 2007/11/17. doi: 10.1016/j.chom.2007.07.003 18005733; PubMed Central PMCID: PMCPmc2719558.
57. Xie L, Mouillet JF, Chu T, Parks WT, Sadovsky E, Knofler M, et al. C19MC microRNAs regulate the migration of human trophoblasts. Endocrinology. 2014;155(12):4975–85. Epub 2014/09/12. doi: 10.1210/en.2014-1501 25211593; PubMed Central PMCID: PMCPmc4239420.
58. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic acids research. 2002;30(4):e15. Epub 2002/02/14. 11842121; PubMed Central PMCID: PMCPmc100354.
59. Wettenhall JM, Smyth GK, limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics (Oxford, England). 2004;20(18):3705–6. Epub 2004/08/07. doi: 10.1093/bioinformatics/bth449 15297296.
60. Storey JD, Tibshirani R, Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(16):9440–5. Epub 2003/07/29. doi: 10.1073/pnas.1530509100 12883005; PubMed Central PMCID: PMCPmc170937.
61. Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, et al. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS pathogens. 2011;7(3):e1001311. Epub 2011/03/26. doi: 10.1371/journal.ppat.1001311 21436888; PubMed Central PMCID: PMCPmc3059221.
62. Zhu J, Zhang Y, Ghosh A, Cuevas RA, Forero A, Dhar J, et al. Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. Immunity. 2014;40(6):936–48. doi: 10.1016/j.immuni.2014.05.007 24931123; PubMed Central PMCID: PMC4101812.